APHCRI Centre of Research Excellence (CRE) in Primary Health Care Microsystems Stream 2, jointly with Improvement Foundation (IF) Australia which runs Australian Primary Care Collaboratives (APCC) Program, commenced a project in March 2014 to investigate the impact of the APCC Program on cardiovascular disease (CVD) outcomes.
“The objective of the APCC Program is to encourage and support general practices throughout Australia in delivering rapid, measurable, systematic and sustainable improvements in the care they provide to patients, through the sound understanding and effective application of quality improvement methods and skills”. Staff from participating practices attend a series of workshops and are introduced to the model for improvement Plan, Do, Study, Act (PDSA) cycles.
Cardiovascular disease is the major cause of death in Australia, 34% of all deaths. Despite the remarkable decline in CVD deaths noticed from late 1960s, 3.7 million (19%) of Australian population have a cardiovascular disease.
The APCC program started a new CVD national wave in March 2014 including a hundred general practices. This study is an observational, longitudinal cohort study to follow up the CVD patients in APCC program (CVD wave) from 1 May 2014 to 1 May 2015. We will assess the changes in improvement measures, risk factors and compliance with medication.
A modified IMPACT mortality model will be used to calculate the effect of improved treatments and risk factor reduction on CVD outcomes. The IMPACT model was used and validated in several countries such as Poland, USA, Iceland, Finland, Sweden, New Zealand, Scotland, England and Wales. This is the first study of CVD outcomes in Collaboratives.
This project is collaboration between Prof James Dunbar and Dr Amr Abou Elnour (APHCRI CRE, Australia), Dr Dale Ford (IF, Australia), Prof Erkki Vartiainen and Prof Tiina Laatikainen (National Public Health Institute, Finland), and Prof Simon Capewell (University of Liverpool, UK).